Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer.
Clinical trial NCT03406650 · COMPLETED
Trial details
- NCT number
- NCT03406650
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2022-02-25
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.